Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Merit Medical Systems (MMSI) Shares Outstanding (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed Shares Outstanding for 17 consecutive years, with $59.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.16% to $59.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.4 million through Dec 2025, up 1.16% year-over-year, with the annual reading at $59.4 million for FY2025, 1.16% up from the prior year.
  • Shares Outstanding hit $59.4 million in Q4 2025 for Merit Medical Systems, roughly flat from $59.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $59.4 million in Q4 2025 to a low of $55.9 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $57.7 million across 5 years, with a median of $57.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding: rose 0.83% in 2022 and later grew 1.76% in 2025.
  • Year by year, Shares Outstanding stood at $56.6 million in 2021, then increased by 1.3% to $57.3 million in 2022, then rose by 0.96% to $57.9 million in 2023, then grew by 1.53% to $58.7 million in 2024, then grew by 1.16% to $59.4 million in 2025.
  • Business Quant data shows Shares Outstanding for MMSI at $59.4 million in Q4 2025, $59.3 million in Q3 2025, and $59.2 million in Q2 2025.